Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of telavancin for Gram-positive bloodstream infections in cancer patients has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Infection

Drugs mentioned

• Telavancin (telavancin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Infection, Bacteremia | Phase 2 | Status: COMPLETED | Results posted: 2019-12-27